Evidence map›Paper›PMID 42629516›Full record

ArticleAnnals of surgical oncology2026

Mastering Robotic SMA Dissection: How the Correct Anatomical Concept Refines Technical Steps in the Left Posterior Approach.

Ryota Ito, Yosuke Inoue, Hayato Baba, Gaku Shimane, Kota Sugiura, Yui Sawa, Yoshiyuki Shibata, Sho Kiritani, Kosuke Kobayashi, Atsushi Oba and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Annals of surgical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ryota ItoDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yosuke InoueDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan. yosuke.inoue@jfcr.or.jp.
Hayato BabaDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Gaku ShimaneDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kota SugiuraDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yui SawaDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yoshiyuki ShibataDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Sho KiritaniDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Kosuke KobayashiDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Atsushi ObaDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Yoshihiro OnoDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Hiromichi ItoDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Ryuji YoshiokaDepartment of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yoshihiro MiseDepartment of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Akio SaiuraDepartment of Hepatobiliary-Pancreatic Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Yu TakahashiDivision of Hepatobiliary and Pancreatic Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe left posterior approach to the superior mesenteric artery (SMA) facilitates central vascular ligation and R0 resection during robotic pancreaticoduodenectomy (PD). PATIENTS AND

methodsThe technique begins with a left-sided scope orientation. The transverse mesocolon was cranially retracted using a Nathanson retractor to create a stable, wide operative field. Traction is achieved through the combination of a robotic traction arm and assistant-assisted retraction, allowing one robotic arm to remain available for precise dissection and prompt hemostasis.

resultsBetween 2021 and 2025, 27 consecutive patients with invasive pancreatic cancer underwent robotic PD using the left posterior approach. The median operative time was 582 min, and the median blood loss was 100 mL. One patient required conversion to gastroduodenal artery bleeding; four underwent planned minilaparotomy for portal vein resection. Notably, no conversion was observed when using the left posterior approach. Clavien-Dindo grade IIIa complications occurred in two patients (7.4%), with no reoperations or mortalities. The rate of R0 resection was 89%.

conclusionsMastering the 3D mesojejunal anatomy and maintaining precise resection planes are fundamental to ensuring safety and optimal oncologic outcomes during the left posterior approach in robotic PD.

Indexed as

3DAnatomyLeft posterior approachPancreaticoduodenectomyRobot-assisted pancreaticoduodenectomyRobotic PDThree-dimensional

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.